---
figid: PMC8566138__enm-2021-1155f7
figtitle: Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist,
  Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38
  MAPK Signaling Pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Candida dubliniensis
pmcid: PMC8566138
filename: enm-2021-1155f7.jpg
figlink: /pmc/articles/PMC8566138/figure/f7-enm-2021-1155/
number: F7
caption: Schematic representation of transforming growth factor-beta1 (TGF-β1)-induced
  epithelial-mesenchymal transition (EMT) and role of lobeglitazone (LGZ), a peroxisome
  proliferator-activated receptor gamma (PPAR-γ) agonist in BRAFV600E-mutated papillary
  thyroid carcinoma cells. LGZ suppresses the p38 mitogen-activated protein kinase
  (MAPK) signaling pathway and finally reduces migration and invasion of papillary
  thyroid carcinoma (PTC) cells induced by TGF-β1. “→” indicates promotion; “⊥” indicates
  inhibition. ERK, extracellular signal-regulated kinase.
papertitle: Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist,
  Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38
  MAPK Signaling Pathway.
reftext: Jun-Qing Jin, et al. Endocrinol Metab (Seoul). 2021 Oct;36(5):1095-1110.
year: '2021'
doi: 10.3803/EnM.2021.1155
journal_title: Endocrinology and Metabolism
journal_nlm_ta: Endocrinol Metab (Seoul)
publisher_name: Korean Endocrine Society
keywords: Thyroid cancer | papillary | PPAR gamma | Neoplasm metastasis
automl_pathway: 0.9377309
figid_alias: PMC8566138__F7
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8566138__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8566138__enm-2021-1155f7.html
  '@type': Dataset
  description: Schematic representation of transforming growth factor-beta1 (TGF-β1)-induced
    epithelial-mesenchymal transition (EMT) and role of lobeglitazone (LGZ), a peroxisome
    proliferator-activated receptor gamma (PPAR-γ) agonist in BRAFV600E-mutated papillary
    thyroid carcinoma cells. LGZ suppresses the p38 mitogen-activated protein kinase
    (MAPK) signaling pathway and finally reduces migration and invasion of papillary
    thyroid carcinoma (PTC) cells induced by TGF-β1. “→” indicates promotion; “⊥”
    indicates inhibition. ERK, extracellular signal-regulated kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mapk14
  - Snai1
  - Tgfb1
  - Ephb1
  - Cdh1
  - Fzr1
  - Mapk8
  - Mmp2
  - Cdh2
  - Slc22a3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - SNAI1
  - TGFB1
  - EPHB2
  - CDH1
  - FZR1
  - MMP2
  - CDH2
  - ITK
  - SLC22A3
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Ephb2
  - Mapk1
  - Itk
---
